Annual report 2021

Proposal of the Board of Directors for the appropriation of the available profit

in CHF

 

2021

Net loss for the year

 

–497’618

Total available profit

 

–497’618

Appropriation from free reserves

 

25’000’000

Ordinary dividend

 

–20’556’185

Balance carried forward

 

3’946’197

 

 

 

Dividend distribution per share CHF 0.01

 

 

Gross dividend

 

0.50

Withholding tax (35%)

 

–0.18

Net dividend

 

0.32

The Board of Directors proposes the payment of a dividend of CHF 0.50 per share to the Annual General Meeting on April 12, 2022. The company will not pay a dividend on treasury shares held by medmix Ltd or one of its subsidiaries.